A Prescription CBD Product for Transformative Anesthesia Care.
A paradigm shifting anesthetic premedication for awake, conscious sedation for surgical and medical procedures.
JOS Pharmaceuticals, a clinical stage pharmaceutical company, has pioneered the se•d8™ wafer, an orally dissolving, all-synthetic CBD drug. Se•d8™ is for use as a prescription premedication for specific medical procedures that require an awake, conscious sedation anesthetic technique.
JOS Pharmaceuticals: CEO, Company Founder and Chief Scientific Officer
Stephen Ochs is a retired, board certified anesthesiologist with over 40 years of clinical experience.
The Cannabis sativa L. plant is the chemical basis of JOS Pharmaceuticals new anesthetic premedication.
Se•d8™ is an orally dissolving, rapidly systemically absorbed, all synthetic CBD formulation. The CBD wafers are individually blister packaged as designed to quickly dissolve on top of the tongue (super-lingual) to facilitate direct transmucosal absorption via the epithelial lining of the oral pharynx.